ENTRY       D11445                      Drug
NAME        Vofatamab (USAN)
FORMULA     C6496H10040N1716O2050S44
EXACT_MASS  146296.1844
MOL_WEIGHT  146386.352
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFT STGISWVRQA PGKGLEWVGR IYPTSGSTNY
            ADSVKGRFTI SADTSKNTAY LQMNSLRAED TAVYYCARTY GIYDLYVDYT EYVMDYWGQG
            TLVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF
            PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP
            APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK
            PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT
            LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL
            TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQDVD TSLAWYKQKP GKAPKLLIYS ASFLYSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ STGHPQTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H154-H210, H230-L214, H236-H'236, H239-H'239, H271-H331, H377-H435, H'22-H'96, H'154-H'210, H'230-L'214, H'271-H'331, H'377-H'435, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-FGFR-3 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of relapsed or refractory advanced urothelial cell carcinoma (UCC)
TARGET      FGFR3 (CD333) [HSA:2261] [KO:K05094]
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               FGFR family
                FGFR3 (CD333)
                 D11445  Vofatamab (USAN)
DBLINKS     CAS: 1312305-12-6
            PubChem: 384585422
///
